Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1995
10/05/1995WO1995026403A1 Antibodies against e-selectin
10/05/1995WO1995026402A1 Vaccines against helminthic parasites
10/05/1995WO1995026365A1 Synthetic peptide based immunogens for the treatment of allergy
10/05/1995WO1995026364A1 Monoclonal antibodies recognizing tie-receptor and their use
10/05/1995WO1995026362A1 Peptides for diagnostics and therapeutics
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026203A1 Wound healing
10/05/1995WO1995026202A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026199A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995WO1995016452A3 Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186595A1 Synthetic peptide based immunogens for the treatment of allergy
10/05/1995CA2186496A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995CA2186455A1 Antibodies against e-selectin
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/05/1995CA2186390A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof
10/05/1995CA2182178A1 Vaccines against helminthic parasites
10/04/1995EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/04/1995EP0675199A2 A DNA which codes for the variable region of the anti-human influenza A type virus antibody recognizing the H,N, and H2N2 subtypes of haemagglutinin
10/04/1995EP0675136A2 Antibodies to mammalian interleukin-4 and peptides useful as antigens in their production
10/04/1995EP0674905A2 Bacterin for the treatment of necrophorum diseases and a method for the production thereof
10/04/1995EP0674710A1 Peptides and anti-sense peptides with broad neoplastic specificity
10/04/1995EP0674661A1 Assay and treatment for demyelinating diseases such as multiple sclerosis
10/04/1995EP0674659A1 Peptides and vaccines derived from nematode tubulin
10/04/1995EP0674658A1 A novel protein tyrosine kinase
10/04/1995EP0674526A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
10/04/1995EP0547059B1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies
10/04/1995EP0529019B1 Nematode vaccine
10/04/1995EP0271577B1 Immunomodulating compositions and their use
10/04/1995CN1109505A Interferon-alpha/beta binding protein, its preparation and use
10/04/1995CN1109503A New strain of ribrio comma and its live vaccine
10/04/1995CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates
10/03/1995US5455330 Isolated pure protein having specified amino acid sequence
10/03/1995US5455240 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof
10/03/1995US5455169 Isolated nucleic acids which code human amyloid precursor protein, for detection and drug screening
10/03/1995US5455159 Method for early detection of lung cancer
10/03/1995US5455034 Fusobacterium necrophorum leukotoxoid vaccine
10/03/1995US5455032 Use of phosphocholine hapten conjugates in vaccines
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
10/03/1995US5455028 Method of inhibiting fungi by Bacillus laterosporus
10/03/1995CA1337181C Recombinant herpes simplex gb-gd vaccine
09/1995
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025806A2 Packaging-deficient lentiviruses
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/28/1995WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
09/28/1995WO1995025744A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
09/28/1995WO1995025742A1 Pasteurellaceae antigens and related vaccines
09/28/1995WO1995025740A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
09/28/1995WO1995025739A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995WO1995025738A1 Recombinase-deficient helicobacter pylori and related methods
09/28/1995WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis
09/28/1995WO1995025542A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug
09/28/1995WO1995025541A1 Bovine neospora isolates and their uses
09/28/1995WO1995025530A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995WO1995025528A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/28/1995WO1994025597A3 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA)
09/28/1995CA2186121A1 Pasteurellaceae antigens and related vaccines
09/28/1995CA2186016A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection
09/28/1995CA2186006A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
09/28/1995CA2186005A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof
09/28/1995CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/27/1995EP0674178A2 Cyclosporin immunoassay
09/27/1995EP0674175A2 Chemical modification of antibodies and antigens
09/27/1995EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications
09/27/1995EP0673948A1 Pepticles derived from a retrovirus of the HIV-group and their use
09/27/1995EP0673653A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it
09/27/1995EP0673426A1 Platelet-activating factor acetylhydrolase
09/27/1995EP0673425A1 Dna encoding chitin deacetylase
09/27/1995EP0673421A1 Allergenic proteins and peptides from johnson grass pollen
09/27/1995EP0673420A1 Mammalian receptors for interleukin-10 (il-10)
09/27/1995EP0673418A1 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
09/27/1995EP0673391A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto
09/27/1995EP0673386A1 Methods and compositions for detecting anti-hepatitis e virus activity
09/27/1995EP0673255A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof
09/27/1995EP0348490B1 Treatment of type 2 diabetes mellitus
09/27/1995EP0261225B1 Lectin complex and method and probe for making same
09/27/1995CN1109260A A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
09/27/1995CN1029857C Preparation of microbiological pharmaceutics
09/26/1995US5453493 Method of precipitating proteins from aqueous media with a polyhydroxy polycarboxylic acid
09/26/1995US5453364 Recombinant poxvirus host range selection system
09/26/1995US5453361 Method for producing biologically active human brain derived neurotrophic factor
09/26/1995US5453359 Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
09/26/1995US5453354 Method for improving sperm motility
09/26/1995US5453273 M. canis containing ringworm vaccine
09/26/1995US5453272 Serine-proline-tyrosine-glycine-arginine-cysteine hexapeptide; immunosuppressant
09/26/1995US5453271 Side effect reduction
09/26/1995CA1337120C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccines containing same
09/26/1995CA1337116C Vaccine for protection of cats against feline infectious peritonitis
09/26/1995CA1337115C Vaccination against rabies-related diseases
09/26/1995CA1337114C Intranasal immunization against viral infection using viral glycoprotein subunit vaccine
09/26/1995CA1337113C Pharmaceutical composition for eliciting an immunostimulant effect
09/22/1995CA2144936A1 Antibody conjugates with improved properties
09/21/1995WO1995025167A1 Anti-egfr single-chain fvs and anti-egfr antibodies
09/21/1995WO1995025132A1 Water insoluble cross-linked polycarbonic acid compositions
09/21/1995WO1995025125A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995WO1995025124A1 Methods to diagnose and treat hiv-1 infection
09/21/1995WO1995025122A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
1 ... 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 ... 1823